Skip to main content
CLB logo
CLB
(NYSE)
Core Laboratories Inc.
$16.33-- (--)
Loading... - Market loading

Core Laboratories (CLB) Key Statistics & Financial Metrics

Complete stock analysis with 40+ metrics: valuation ratios, profitability margins, financial health indicators, and dividend data.

Stock Valuation Metrics

Market value, earnings multiples, and pricing ratios

Market Valuation & Earnings Multiples

Market capitalization, P/E ratios, and enterprise value

Market Cap759.35M
Enterprise Value932.60M
Trailing P/E23.55
Forward P/E23.26

Price-Based Ratios

Valuation ratios based on stock price

Price/Sales (ttm)1.42
Forward Price/Sales1.42
Price/Book (mrq)2.68
Price/Tangible Book (mrq)12.70
Price/FCF (ttm)33.36
Price/OCF (ttm)20.25

Enterprise Value Ratios

EV-based valuation multiples

EV/Revenue1.77
EV/Earnings29.32
EV/EBITDA13.38
EV/EBIT17.02
EV/FCF41.53

Stock Price

Current price, 52-week range, and moving averages

Current Price$16.33
1-Day Change-4.05%
52-Week High$20.36
52-Week Low$9.72
52-Week Change7.54%
YTD Change-4.96%
1-Year Change7.98%
50-Day MA$17.67
200-Day MA$14.65
Avg Volume (30 day)247.06K

Share Statistics

Outstanding shares, float, and per-share metrics

Shares Outstanding46.50M
Book Value per Share$6.02
Net Cash per Share$0.25
FCF per Share$0.48

Profitability & Financial Performance

Profit margins, return metrics, and earnings analysis

Profit Margins

Profitability margins across income statement

Gross Margin17.91%
EBITDA Margin (ttm)13.24%
EBIT Margin (ttm)10.41%
Operating Margin (ttm)9.33%
Pretax Margin (ttm)8.72%
Profit Margin (ttm)6.04%
FCF Margin (ttm)4.27%

Return on Investment Metrics

ROE, ROA, ROIC, and capital efficiency ratios

Return on Equity (ttm)11.37%
Return on Assets (ttm)5.33%
Return on Invested Capital (ttm)8.20%
Return on Capital Employed (ttm)11.19%

Income Statement (TTM)

Trailing twelve months revenue and earnings

Revenue526.52M
Gross Profit94.28M
Operating Income49.13M
Pretax Income45.90M
Net Income31.80M
EBITDA69.72M
EBIT54.81M
Diluted EPS$0.68

Cash Flow (TTM)

Operating cash flow and free cash flow metrics

Operating Cash Flow37.00M
Capital Expenditures14.54M
Free Cash Flow22.46M

Growth Rates (YoY)

Year-over-year growth metrics

Revenue Growth0.51%
Dividend Growth0.00%

Financial Health & Dividends

Balance sheet analysis, debt ratios, and dividend metrics

Assets & Cash

Total assets and cash positions

Total Assets (mrq)596.95M
Cash & Securities (mrq)22.85M
Net Cash (mrq)11.39M
Net Cash per Share$0.25

Debt & Liabilities

Liabilities, debt, equity, and working capital

Total Debt (mrq)206.33M
Working Capital (mrq)115.19M
Total Equity (mrq)279.76M
Book Value per Share$6.02

Liquidity & Leverage

Liquidity, leverage, and debt coverage ratios

Current Ratio (mrq)2.07
Quick Ratio (mrq)1.57
Debt/Equity (mrq)0.74
Debt/EBITDA (ttm)2.96
Debt/FCF (ttm)9.19

Dividend History & Payout Analysis

Dividend yield, payout ratios, and growth metrics

Dividend per Share (TTM)$0.04
Dividend Yield0.25%
Payout Ratio (Earnings)5.85%
Payout Ratio (FCF)8.28%
Dividend Growth (YoY)0.00%
Ex-Dividend DateFeb 13, 2026
Pay DateMar 9, 2026
Dividend FrequencyQuarterly

Yield Metrics

Earnings, FCF, buyback, and shareholder yields

Earnings Yield4.25%
FCF Yield3.00%
Buyback Yield1.66%
Total Shareholder Yield1.91%

Financial Health Scores

Risk assessment and quality metrics

Altman Z-Score2.83
Piotroski F-Score5/9
Dividend Score12.38

Fair Value & Intrinsic Value

Lynch fair value, Graham number, and valuation models

Lynch Fair Value$14.29
Lynch Upside/Downside-11.29%
Graham Number$9.62
Graham Upside/Downside-40.27%

Frequently Asked Questions About Core Laboratories Statistics

What are the key financial metrics for CLB?

Core Laboratories Inc. (CLB) statistics include 40+ financial metrics organized into valuation ratios (P/E, P/S, P/B, PEG), profitability margins (gross, operating, net), return metrics (ROE, ROA, ROIC), and financial health indicators. These are updated regularly based on the latest filings and market data.

What is CLB's valuation analysis?

The valuation section covers market capitalization, earnings multiples like trailing and forward P/E, price-based ratios (P/S, P/B, Price/FCF), and enterprise value ratios (EV/EBITDA, EV/Revenue, EV/FCF). Compare these against sector averages to assess whether Core Laboratories is overvalued or undervalued.

How do I read CLB's profitability ratios?

Core Laboratories's profitability is measured through profit margins (gross, EBITDA, operating, net) and return metrics (ROE, ROA, ROIC, ROCE). Higher margins indicate better cost control, while higher returns show efficient capital deployment. The income statement and cash flow sections provide the underlying revenue and earnings data.

What do CLB's debt ratios indicate?

The financial health section shows Core Laboratories's leverage through debt-to-equity, debt-to-assets, debt-to-EBITDA, and debt-to-FCF ratios, plus liquidity via the current and quick ratios. Lower debt ratios and higher liquidity ratios generally indicate stronger financial stability and lower default risk.

What is CLB's dividend analysis?

The dividend section covers Core Laboratories's dividend yield, payout ratios (earnings-based and FCF-based), year-over-year dividend growth, years of consecutive growth, ex-dividend and pay dates, and payment frequency. The yield metrics section also includes earnings yield, FCF yield, buyback yield, and total shareholder yield.